Changes in Renal Function with Aging
Tóm tắt
The most important clinical renal function to monitor with aging is the glomerular filtration rate (creatinine clearance). Most decisions on drug dosage can be based on this information alone as other (tubular) functions of the kidney decrease at rates paralleling the decrease in glomerular filtration rate. As individuals age, mean creatinine clearances fall at a rate approximating 1% per year and there is an increasing variance in creatinine clearances making it increasingly important to adjust drug dosages for changes in renal function. Since muscle mass and urinary creatinine excretions decrease at nearly the same rate, mean serum creatinine concentrations stay nearly constant. One must be aware of this phenomenon when using serum creatinine concentrations alone to determine drug dosages and intervals.
Tài liệu tham khảo
Adler S, Lindeman RD, Yiengst MJ, Beard ES, Shock NW. Effect of acute acid loading on urinary acid excretion by the aging human kidney. Journal of Laboratory and Clinical Medicine 72: 278–289, 1968
Agarwal N, Cabebe FG. Renal acidification in elderly subjects. Nephron 26: 291–293, 1980
Bennett WM. Appendix D — Guide to Drug Dosage in Renal Failure; and Dettli L. Appendix E — Nomogram Method for Dose Stimulation in Renal Failure. In Speight (Ed.) A very’s drug treatment: principles and practice of clinical pharmacology and therapeutics, pp. 1414-1447, ADIS Press, Auckland, New Zealand and Williams and Wilkins, Baltimore, 1987
Bennett WM, Muther RS, Parker RA, Feig P, Morrison G, et al. Drug therapy in renal failure: dosing guidelines in adults. Part I. Antimicrobial agents, analgesics. Part II. Sedatives, hypnotics, and tranquilizers; cardiovascular, and diuretic agents; miscellaneous agents. Annals of Internal Medicine 93: 62–89, 286-325, 1980
Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. New England Journal of Medicine 307: 652–659, 1982
Bryan CS, Stone WJ. Antimicrobial dosage in renal failure: a unifying nomogram. Clinical Nephrology 7: 81–84, 1977
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41, 1976
Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. Journal of Clinical Investigation 29: 496–507, 1950
Dontas AS, Marketos SG, Papanayiotou P. Mechanism of renal tubular defects in old age. Post Graduate Medical Journal 48: 295–303, 1972
Fine LG. Preventing the progression of human renal disease: have rational therapeutic principles emerged? Kidney International 33: 116–128, 1988
Gibson TP. Influence of renal disease on pharmacokinetics. In Evans et al. (Eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, pp. 32–56, Applied Therapeutics, San Francisco, 1980
Hakim RM, Goldszer RC, Brenner BM. Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney International 25: 930–936, 1984
Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abram LA, et al. Senescence and the renal vasculature in normal man. Circulation Research 34: 309–316, 1974
Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. American Journal of Physiology 9: F85–F93, 1981
Lindeman RD, Goldman R. Anatomic and physiologic age changes in the kidney. Experimental Gerontology 21: 379–406, 1986
Lindeman RD, Lee RD Jr, Yiengst MJ, Shock NW. Influence of age, renal disease, hypertension, diuretics and calcium on the antidiuretic response to suboptimal infusions of vasopressin. Journal of Laboratory and Clinical Medicine 68: 206–223, 1966
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. Journal of the American Geriatrics Society 33: 278–285, 1985
Lindeman RD, Van Buren HC, Raisz LG. Osmolar renal concentrating ability in healthy young men and hospitalized patients without renal disease. New England Journal of Medicine 262: 1306–1309, 1960
Lindeman RD. Overview: renal physiology and pathophysiology of aging. American Journal of Kidney Disease 16: 275–282, 1990
McDonald RF, Solomon DH, Shock NW. Aging as a factor in the renal hemodynamic changes induced by a standardized pyrogen. Journal of Clinical Investigation 5: 457–462, 1951
Miller JH, McDonald RK, Shock NW. The renal extraction of paminohippurate in the aged individual. Journal of Gerontology 6: 213–216, 1951
Miller JH, McDonald RK, Shock NW. Age changes in the maximal rate of renal tubular reabsorption of glucose. Journal of Gerontology 7: 196–200, 1952
Miller JH, Shock NW. Age differences in the renal tubular response to antidiuretic hormone. Journal of Gerontology 8: 446–450, 1953
Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney International 32: 1–12, 1987
Phillips PA, Rolls BJ, Ledingham JJG, Forsling ML, Morton JJ, et al. Reduced thirst after water deprivation in healthy elderly men. New England Journal of Medicine 311: 753–759, 1984
Rowe JW, Andres R, Tobin JD, Shock NW. The effect of age on creatinine clearance in men: a cross sectional and longitudinal study. Journal of Gerontology 31: 155–163, 1976
Rowe JW, Kahn RL. Human aging: usual and successful. Science 237: 143–149, 1987
Rowe JW, Shock NW, DeFronzo RA. The influence of age on the renal response to water deprivation in man. Nephron 17: 270–278, 1976
Shock NW, Yiengst MJ. Age changes in the acid-base equilibrium of the blood of males. Journal of Gerontology 5: 1–4, 1950
Wesson LG Jr. Renal hemodynamics in physiological states. In Wesson LG Jr (Ed.) Physiology of the human kidney, pp. 98–100, Grune & Stratton, New York, 1969